Telescope Innovations Corp. (TELIF)

0.3200 0.0000 (0.00%) At close: 04:00PM EDT

Telescope Innovations Corp.

301 - 2386 East Mall
Vancouver, BC V6T 1Z3
Canada
778 262 1166
https://www.telescopeinnovations.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Henry Dubina	CEO & Chairman of Board	N/A	N/A	N/A
Prof. Jason Hein	CTO & Director	212.21k	N/A	N/A
Mr. John Kirincic	Chief Financial Officer	N/A	N/A	N/A
Dr. Jeffrey W. Sherman Ph.D.	Chief Operating Officer	N/A	N/A	N/A
Ms. Deborah Cotter	Company Secretary	N/A	N/A	N/A
Shad Grunert	Vice President of Innovation	4.91k	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry. It has a research collaboration with Pfizer Inc; and Standard Lithium Ltd. to develop a method for producing high-purity lithium sulfide. The company is based in Vancouver, Canada.

Corporate Governance

Telescope Innovations Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.